European Commission Approves LORVIQUA (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer Read more
CHMP recommends approval of Dupixent (dupilumab) for children aged 6 to 11 years with severe asthma with type 2 inflammation Read more
Invitation from the conference chairman for SMi’s 5th Annual Pharmaceutical Microbiology East Coast Conference Read more
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics Read more
EC Approves Merck’s KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery Read more
Cocrystal Pharma Selects Two Lead Antiviral Drug Candidates for its COVID-19 Oral Drug Program Read more